Article
Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study.
JMIR public health and surveillance - 15 Jul 2024
Holdefer Ashley A, Pizarro Jeno, Saunders-Hastings Patrick, Beers Jeffrey, Sang Arianna, Hettinger Aaron Zachary, Blumenthal Joseph, Martinez Erik, Jones Lance Daniel, Deady Matthew, Ezzeldin Hussein, Anderson Steven A
Abstract excerpt
BACKGROUND: Adverse events associated with vaccination have been evaluated by epidemiological studies and more recently have gained additional attention with the emergency use authorization of several COVID-19 vaccines. As part of its responsibility to conduct postmarket surveillance, the US Food and Drug Administration continues to monitor several adverse events of special interest (AESIs) to ensure vaccine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.